Cigna Group (CIGN) Stock Overview
Provides insurance and related products and services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
CIGN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Cigna Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$245.00 |
| 52 Week High | US$285.80 |
| 52 Week Low | US$210.90 |
| Beta | 0.31 |
| 1 Month Change | 3.29% |
| 3 Month Change | 3.84% |
| 1 Year Change | -11.28% |
| 3 Year Change | 7.60% |
| 5 Year Change | 14.38% |
| Change since IPO | 77.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| CIGN | AT Healthcare | AT Market | |
|---|---|---|---|
| 7D | -2.2% | 0.6% | 0.9% |
| 1Y | -11.3% | -8.3% | 25.4% |
Return vs Industry: CIGN underperformed the Austrian Healthcare industry which returned -7.6% over the past year.
Return vs Market: CIGN underperformed the Austrian Market which returned 24.5% over the past year.
Price Volatility
| CIGN volatility | |
|---|---|
| CIGN Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in AT Market | 6.8% |
| 10% least volatile stocks in AT Market | 2.8% |
Stable Share Price: CIGN has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: CIGN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1792 | 66,685 | David Cordani | www.thecignagroup.com |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
The Cigna Group Fundamentals Summary
| CIGN fundamental statistics | |
|---|---|
| Market cap | €64.28b |
| Earnings (TTM) | €5.42b |
| Revenue (TTM) | €239.43b |
Is CIGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CIGN income statement (TTM) | |
|---|---|
| Revenue | US$277.89b |
| Cost of Revenue | US$252.47b |
| Gross Profit | US$25.42b |
| Other Expenses | US$19.14b |
| Earnings | US$6.29b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 30, 2026
| Earnings per share (EPS) | 23.77 |
| Gross Margin | 9.15% |
| Net Profit Margin | 2.26% |
| Debt/Equity Ratio | 72.8% |
How did CIGN perform over the long term?
See historical performance and comparisonDividends
Does CIGN pay a reliable dividends?
See CIGN dividend history and benchmarks| Cigna Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 04 2026 |
| Dividend Pay Date | Jun 18 2026 |
| Days until Ex dividend | 11 days |
| Days until Dividend pay date | 25 days |
Does CIGN pay a reliable dividends?
See CIGN dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/22 12:59 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Cigna Group is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |